Lung cancer stem cells: Progress and prospects

Cancer Letters

Volumn 338, Issue 1, 2013, Pages 89-93

  Lundin, Amber ^a,b   Driscoll, Barbara ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b PASADENA CITY COLLEGE   (United States)

Author keywords

Cancer stem cells; Epithelial stem cells; Lung cancer

Indexed keywords

CD133 ANTIGEN; NOTCH RECEPTOR; SONIC HEDGEHOG PROTEIN; TUMOR MARKER; WNT PROTEIN;

CANCER GROWTH; CANCER LOCALIZATION; CANCER STEM CELL; CELL FUNCTION; CELL PROLIFERATION; CELL RENEWAL; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; HOMEOSTASIS; HUMAN; INTRACELLULAR SIGNALING; LUNG CANCER; LUNG CARCINOGENESIS; LUNG DEVELOPMENT; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; SHORT SURVEY; TARGET CELL; TUMOR MICROENVIRONMENT;

ERINACEIDAE;

EID: 84882855823     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.08.014     Document Type: Review

References (77)

1. Dingli D., Traulsen A., Michor F. (A)symmetric stem cell replication and cancer. PLoS Comput. Biol. 2007, 3:e53.
2. Morrison S.J., Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006, 441:1068-1074.
3. Snippert H.J., van der Flier L.G., Sato T., van Es J.H., van den Born M., Kroon-Veenboer C., Barker N., Klein A.M., van Rheenen J., Simons B.D., Clevers H. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 2010, 143:134-144.
4. El-Hashash A.H., Warburton D. Cell polarity and spindle orientation in the distal epithelium of embryonic lung. Dev. Dyn. 2011, 240:441-445.
5. He S., Nakada D., Morrison S.J. Mechanisms of stem cell self-renewal. Annu. Rev. Cell Dev. Biol. 2009, 25:377-406.
6. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
7. Nimmo R.A., Slack F.J. An elegant miRror: microRNAs in stem cells, developmental timing and cancer. Chromosoma 2009, 118:405-418.
8. Pardal R., Clarke M.F., Morrison S.J. Applying the principles of stem-cell biology to cancer. Nat. Rev. 2003, 3:895-902.
9. Van Scoyk M., Randall J., Sergew A., Williams L.M., Tennis M., Winn R.A. Wnt signaling pathway and lung disease. Translational Res. 2008, 151:175-180.
10. Warburton D., Berberich M., Driscoll B. Stem/progenitor cells in lung morphogenesis, repair and regeneration. Curr. Top. Dev. Biol. 2004, 64:1-16.
11. Kim C.F., Jackson E.L., Woolfenden A.E., Lawrence S., Babar I., Vogel S., Crowley D., Bronson R.T., Jacks T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005, 121:823-835.
12. Reynolds S.D., Malkinson A.M. Clara cell: progenitor for the bronchiolar epithelium. Int. J. Biochem. Cell Biol. 2010, 42:1-4.
13. Griffiths M.J., Bonnet D., Janes S.M. Stem cells of the Alveolar epithelium. Lancet 2005, 366:249-260.
14. Peacock C.D., Watkins D.N. Cancer stem cells and the ontogeny of lung cancer. J. Clin. Oncol. 2008, 26:2883-2889.
15. Yagui-Beltran A., He B., Jablons D.M. The role of cancer stem cells in neoplasia of the lung: past, present and future. Clin. Transl. Oncol. 2008, 10:719-725.
16. MacKinnon A.C., Kopatz J., Sethi T. The molecular and cellular biology of lung cancer: identifying novel therapeutic strategies. Br. Med. Bull. 2010, 95:47-61.
17. Snyder J.C., Teisanu R.M., Stripp B.R. Endogenous lung stem cells and contribution to disease. J. Pathol. 2009, 217:254-264.
18. Sullivan J.P., Minna J.D., Shay J.W. Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy. Cancer Metast. Rev. 2010, 29:61-72.
19. Dong J., Kislinger T., Jurisica I., Wigle D.A. Lung cancer developmental networks gone awry?. Cancer Biol. Ther. 2009, 8:312-318.
20. Peebles K.A., Lee J.M., Mao J.T., Hazra S., Reckamp K.L., Krysan K., Dohadwala M., Heinrich E.L., Walser T.C., Cui X., Baratelli F.E., Garon E., Sharma S., Dubinett S.M. Inflammation and lung carcinogenesis: applying findings in prevention and treatment. Expert Rev. Anticancer Ther. 2007, 7:1405-1421.
21. Walser T., Cui X., Yanagawa J., Lee J.M., Heinrich E., Lee G., Sharma S., Dubinett S.M. Smoking and lung cancer: the role of inflammation. Proc. Am. Thorac. Soc. 2008, 5:811-815.
22. Kundu J.K., Surh Y.J. Inflammation: gearing the journey to cancer. Mutat. Res. 2008, 659:15-30.
23. Kundu J.K., Surh Y.J. Emerging avenues linking inflammation and cancer. Free Radic. Biol. Med. 2012, 52:2013-2037.
24. Gonda T.A., Tu S., Wang T.C. Chronic inflammation, the tumor microenvironment and carcinogenesis. Cell Cycle 2009, 8:2005-2013.
25. Yagui-Beltran A., Jablons D.M. A translational approach to lung cancer research. Ann. Thorac. Cardiovasc. Surg. 2009, 15:213-220.
26. Sutherland K.D., Berns A. Cell of origin of lung cancer. Mol. Oncol. 2010, 4:397-403.
27. Rahman M., Deleyrolle L., Vedam-Mai V., Azari H., Abd-El-Barr M., Reynolds B.A. The cancer stem cell hypothesis: failures and pitfalls. Neurosurgery. 2011, 68:531-545.
28. Tysnes B.B., Bjerkvig R. Cancer initiation and progression: involvement of stem cells and the microenvironment. BBA-Rev. Cancer. 2007, 1775:283-297.
29. Guo W., Lasky J.L., Wu H. Cancer stem cells. Pediatr. Res. 2006, 59:59R-64R.
30. Girouard S.D., Murphy G.F. Melanoma stem cells: not rare, but well done. Lab. Invest. 2011, 91:647-664.
31. Buzzeo M.P., Scott E.W., Cogle C.R. The hunt for cancer-initiating cells: a history stemming from leukemia. Leukemia 2007, 21:1619-1627.
32. Glinsky G.V. "Stemness" genomics law governs clinical behavior of human cancer: implications for design making in disease management. J. Clin. Oncol. 2008, 26:2846-2853.
33. Clarke M.F., Fuller M. Stem cells and cancer: two faces of Eve. Cell 2006, 124:1111-1115.
34. Fang D., Nguyen T.K., Leishear K., Finko R., Kulp A.N., Hotz S., Van Belle P.A., Xu X., Elder D.E., Herlyn M. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 2005, 65:9328-9337.
35. Rock J.R., Onaitis M.W., Rawlins E.L., Lu Y., Clark C.P., Xue Y., Randell S.H., Hogan B.L. Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc. Natl. Acad. Sci. USA 2009, 106:12771-12775.
36. Hong K.U., Reynolds S.D., Watkins S., Fuchs E., Stripp B.R. Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am. J. Pathol. 2004, 164:577-588.
37. Liu X., Driskell R.R., Engelhardt J.F. Stem cells in the lung. Methods Enzymol. 2006, 419:285-321.
38. 2. Am. J. Pathol. 1973, 70:175-198.
39. Jackson S.R., Lee J., Reddy R., Williams G.N., Kikuchi A., Freiberg Y., Warburton D., Driscoll B. Partial pneumonectomy of telomerase null mice carrying shortened telomeres initiates cell growth arrest resulting in a limited compensatory growth response. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 300:L898-L909.
40. Kim C. Paving the road for lung stem cell biology: bronchioalveolar stem cells and other putative distal lung stem cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 293:L1092-L1098.
41. Berns A. Stem cells for lung cancer?. Cell 2005, 121:811-813.
42. Kratz J.R., Yagui-Beltran A., Jablons D.M. Cancer stem cells in lung tumorigenesis. Ann. Thorac. Surg. 2010, 89:S2090-S2095.
43. Rawlins E.L., Okubo T., Xue Y., Brass D.M., Auten R.L., Hasegawa H., Wang F., Hogan B.L. The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell 2009, 4:525-534.
44. Xu X., Rock J.R., Lu Y., Futtner C., Schwab B., Guinney J., Hogan B.L., Onaitis M.W. Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma. Proc. Natl. Acad. Sci. USA 2012, 109:4910-4915.
45. Reddy R., Buckley S., Doerken M., Barsky L., Weinberg K., Anderson K.D., Warburton D., Driscoll B. Isolation of a putative progenitor subpopulation of alveolar epithelial type 2 cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 286:L658-L667.
46. Lee J., Reddy R., Barsky L., Weinberg K., Driscoll B. Contribution of proliferation and DNA damage repair to alveolar epithelial type 2 cell recovery from hyperoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 290:L685-L694.
47. Alison M.R. Stem cells and cancer in the aerodigestive tract. Eur. J. Cancer 2009, 45:175-185.
48. Chapman H.A. Epitheilial-mesenchymal interactions in pulmonary fibrosis. Annu. Rev. Physiol. 2011, 73:413-435.
49. Chen Y.C., Hsu H.S., Chen Y.W., Tsai T.H., How C.K., Wang C.Y., Hung S.C., Chang Y.L., Tsai M.L., Lee Y.Y., Ku H.H., Chiou S.H. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS ONE 2008, 3:e2637.
50. Giangreco A., Groot K.R., Janes S.M. Lung cancer and lung stem cells strange bedfellows?. Am. J. Respir. Crit. Care Med. 2007, 175:547-553.
51. Gomperts B.N., Spira A., Massion P.P., Walser T.C., Wistuba I.I., Minna J.D., Dubinett S.M. Evolving concepts in lung carcinogenesis. Semin. Respir. Crit. Care Med. 2011, 32:32-43.
52. Sullivan J.P., Minna J.D. Tumor oncogenotypes and lung cancer stem cell identity. Cell Stem Cell 2010, 7:2-4.
53. Alison M.R., Le Brenne A.C., Islam S. Stem cells and lung cancer: future therapeutic targets?. Expert Opin. Biol. Ther. 2009, 9:1127-1141.
54. Adcock I.M., Caramori G., Barnes P.J. Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration 2011, 81:265-284.
55. Mimeault M., Hauke R., Mehta P.P., Batra S.K. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J. Cell Mol. Med. 2007, 11:981-1011.
56. Spike B.T., Wahl G.M. P53, stem cells, and reprogramming: tumor suppression beyond guarding the genome. Genes Cancer. 2011, 2:404-419.
57. Ding X.W., Wu J.H., Jiang C.P. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sci. 2010, 86:631-637.
58. Bertolini G., Roz L., Perego P., Tortoreto M., Fontanella E., Gatti L., Pratesi G., Fabbri A., Andriani F., Tinelli S., Roz E., Caserini R., Lo Vullo S., Camerini T., Mariani L., Delia D., Calabrò E., Pastorino U., Sozzi G. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc. Natl. Acad. Sci. USA 2009, 106:16281-16286.
59. Abbott B.L. ABCG2 (BCRP): a cytoprotectant in normal and malignant stem cells. Clin. Adv. Hematol. Oncol. 2006, 4:63-72.
60. Das B., Tsuchida R., Malkin D., Koren G., Baruchel S., Yeger H. Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells 2008, 26:1818-1830.
61. Salcido C.D., Larochelle A., Taylor B.J., Dunbar C.E., Varticovski L. Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer. Br. J. Cancer 2010, 102:1636-1644.
62. Shi Y., Fu X., Hua Y., Han Y., Lu Y., Wang J. The side population in human lung cancer cell line NCI-H460 is enriched in stem-like cancer cells. PLoS ONE 2012, 7:e33358.
63. Hirschmann-Jax C., Foster A.E., Wulf G.G., Nuchtern J.G., Jax T.W., Gobel U., Goodell M.A., Brenner M.K. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. USA 2004, 101:14228-14233.
64. Camilli T.C., Weeraratna A.T. Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression. Biochem. Pharmacol. 2010, 80:702-711.
65. Gehrke I., Gandhirajan R.K., Kreuzer K.A. Targeting the Wnt/β-catenin/TCF/Lef1 axis in solid and haematological cancers: multiplicity of therapeutic options. Eur. J. Cancer 2009, 45:2759-2767.
66. He B., Barg R.N., You L., Xu Z., Reguart N., Mikami I., Batra S., Rosell R., Jablons D.M. Wnt signaling in stem cells and non-small-cell lung cancer. Clin. Lung Cancer. 2005, 7(1):54-60.
67. Mazieres J., He B., You L., Xu Z., Jablons D.M. Wnt signaling in lung cancer. Cancer Lett. 2005, 222:1-10.
68. García Campelo M.R., Alonso Curbera G., Aparicio Gallego G., Grande Pulido E., Antón Aparicio L.M. Stem cell and lung cancer development: blaming the Wnt, Hh and Notch signalling pathway. Clin. Transl. Oncol. 2011, 13:77-83.
69. Katoh Y., Katoh M. Hedgehog signaling pathway and gastrointestinal stem cell signaling network (review). Int. J. Mol. Med. 2006, 18:1019-1023.
70. Chi S., Huang S., Li C., Zhang X., He N., Bhutani M.S., Jones D., Castro C.Y., Logrono R., Haque A., Zwischenberger J., Tyring S.K., Zhang H., Xie J. Activation of the hedgehog pathway in a subset of lung cancers. Cancer Lett. 2006, 244:53-60.
71. Watkins D.N., Berman D.M., Baylin S.B. Hedgehog signaling: progenitor phenotype in small-cell lung cancer. Cell Cycle 2003, 2:196-198.
72. Daniel V.C., Peacock C.D., Watkins D.N. Developmental signalling pathways in lung cancer. Respirology 2006, 11:234-240.
73. Gupta S., Takebe N., Lorusso P. Targeting the Hedgehog pathway in cancer. Ther. Adv. Med. Oncol. 2010, 2:237-250.
74. Dang T.P. Notch, apoptosis and cancer. Adv. Exp. Med. Biol. 2012, 727:199-209.
75. Xu K., Moghal N., Egan S.E. Notch signaling in lung development and disease. Adv. Exp. Med. Biol. 2012, 727:89-98.
76. Carlson M.E., O'Connor M.S., Hsu M., Conboy I.M. Notch signaling pathway and tissue engineering. Front. Biosci. 2007, 12:5143-5156.
77. South A.P., Cho R.J., Aster J.C. The double-edged sword of Notch signaling in cancer. Semin. Cell Dev. Biol. 2012, 10.1016/j.semcbd.2012.01.017.